A Response to: Letter to the Editor Regarding A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor- α Inhibitors: The NETWORK-004 Prospective Observational Study

Source: Rheumatology and Therapy - Category: Rheumatology Source Type: research
More News: Rheumatology | Study